anxiety disorder obsessive compulsive disorder
Conditions
Interventions
Participants are offered an individual intensive exposure treatment by a team
of experts, with an intensive phase of 4 weeks with 4 contact moments per week
and a subsequent booster phase of 4 weeks
Sponsors
ProPersona (Nijmegen)
Eligibility
Age
65 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients aged 65 and older who are in treatment or have been registered through their GP for treatment within the outpatient elderly team of a mental health care organization in Gelderland (Pro Persona). They were diagnosed with one of the following anxiety disorders using the Mini International Neuropsychiatric Interview-Simplified (MINI-S): panic disorder, with or without agoraphobia, social anxiety disorder, generalized anxiety disorder, or obsessive-compulsive disorder as a main or additional diagnosis. Other inclusion criteria for the study are: 1) Willingness and ability to follow the 8-week intensive treatment. 2) Sufficient cognitive abilities (score on the Montreal Cognitive Assessment (MOCA) of greater than or equal to 18) 3) Able to read and write the Dutch language. 4) Informed consent for the research after extensive oral and written information.
Exclusion criteria
Exclusion criteria: Exclusion criteria are: an acute psychotic disorder, a severe mood disorder, severe developmental disorders and substance abuse or dependence. Concomitant use of antidepressants and benzodiazepines (maximum daily equivalence of 30 mg oxazepam) is permitted. Participants will be instructed to keep the current dose constant and to take the medication at regular times throughout the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to investigate whether the intensive exposure treatment of 8 weeks leads to a reduction in complaints with older patients with anxiety or obsessive-compulsive disorders, measured with the Geriatric Anxiety Inventory (GAI) and disorder-specific questionnaires. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective is whether the treatment leads to a reduction in depressive symptoms and an improvement in the perceived quality of life as well. Feasibility is operationalized in the number of completed therapy sessions, the rate of dropout and satisfaction with the treatment. | — |
Countries
Netherlands
Outcome results
None listed